Canada
Axolotl Biosciences, founded in 2020, is a promising player in the Biotechnology industry, headquartered in Canada. The company is quickly garnering attention for its innovative approach to advancing medical science through its novel bioink, as reflected in their slogan, "A start-up biotech company striving to advance in the field of medical science through our novel bioink."
In a relatively short time, Axolotl Biosciences has developed a unique suite of offerings that include functional bioinks, 3D tissue models, and consulting services in the burgeoning field of 3D bioprinting. These innovations are strategically designed to significantly enhance human health through cutting-edge technology.
The company's forward momentum is underscored by its last noted funding, a grant investment received on 18 January 2023 from Innovate BC. This financial backing not only validates their pioneering work but also positions them for future scale and impact in the global biotechnology landscape.
